GraniteShares Advisors’s Boston Scientific BSX Stock Holding History

GraniteShares Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$647K	Buy	15,164 +1,565	+12%	+$85K	0.42%	66
2026 Q1	$853K	Buy	13,599 +195	+1%	+$15.6K	0.61%	56
2025 Q4	$1.28M	Buy	13,404 +1,197	+10%	+$117K	0.78%	52
2025 Q3	$1.19M	Buy	12,207 +567	+5%	+$58.7K	0.69%	56
2025 Q2	$1.25M	Sell	11,640 -521	-4%	-$52.7K	0.77%	53
2025 Q1	$1.23M	Sell	12,161 -1,789	-13%	-$180K	0.78%	53
2024 Q4	$1.25M	Sell	13,950 -2,450	-15%	-$216K	0.79%	54
2024 Q3	$1.37M	Sell	16,400 -753	-4%	-$59.4K	0.93%	50
2024 Q2	$1.32M	Buy	+17,153	New	+$1.26M	0.44%	53
2023 Q3	–	Sell	-4,042	Closed	-$219K	–	103
2023 Q2	$219K	Sell	4,042 -232	-5%	-$12.1K	0.2%	103
2023 Q1	$214K	Buy	+4,274	New	+$201K	0.19%	111
2022 Q3	–	Sell	-5,425	Closed	-$202K	–	136
2022 Q2	$202K	Buy	+5,425	New	+$221K	0.15%	136

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GraniteShares Advisors's BSX Position: Q2 2026 in Review

GraniteShares Advisors increased its Boston Scientific (BSX) stake by 12% in Q2 2026, buying an estimated $85K and bringing the position to 15,164 shares worth $647K. The position accounts for 0.42% of the portfolio, ranked #66.

GraniteShares Advisors first reported a position in BSX in Q2 2022 and has held it in 12 quarters since. The position peaked at $1.37M in Q3 2024. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

GraniteShares Advisors held 15,164 shares of Boston Scientific worth $647K as of Q2 2026.
GraniteShares Advisors bought 1,565 Boston Scientific shares in Q2 2026, an estimated $85K.
Boston Scientific made up 0.42% of GraniteShares Advisors's portfolio in Q2 2026, its #66 holding.
GraniteShares Advisors first reported a position in Boston Scientific in Q2 2022 and has held it in 12 quarters since.
GraniteShares Advisors's Boston Scientific position peaked at $1.37M in Q3 2024.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on GraniteShares Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.